Corcept Therapeutics (FRA:HTD) Tax Provision : €-22.5 Mil (TTM As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Corcept Therapeutics Tax Provision?

Corcept Therapeutics's tax provision for the three months ended in Sep. 2024 was €-5.2 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was €-22.5 Mil.

Corcept Therapeutics Tax Provision Historical Data

The historical data trend for Corcept Therapeutics's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Tax Provision Chart

Corcept Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-20.25

-21.04

-11.06

-13.95

-16.89

Corcept Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															-4.69	-5.00	-6.65	-5.67	-5.16

Corcept Therapeutics Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-22.5 Mil.

Corcept Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (FRA:HTD) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

CORT:USA 0I3Q:UK HTD:Germany

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.